NEUROBO PHARMACEUTICALS APPOINTS HYUNG HEON KIM AS CHIEF EXECUTIVE OFFICER AND PRESIDENT
- Monday, August 14, 2023, 7:02
- Finance
- Add a comment
BOSTON, Aug. 14, 2023 /PRNewswire/ — NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced the appointment of current Board member, Hyung Heon (“H.H.”) Kim, as the Company’s Chief Executive…
About the Author
adminasapcorp has written 39579 stories on this site.